ALK-Abello A/S (AKBLF)
37.92
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
ALK-Abello Total Assets (Quarterly) : 1.487B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.487B |
| March 31, 2026 | 1.432B |
| December 31, 2025 | 1.442B |
| September 30, 2025 | 1.334B |
| June 30, 2025 | 1.301B |
| March 31, 2025 | 1.186B |
| December 31, 2024 | 1.234B |
| September 30, 2024 | 1.070B |
| June 30, 2024 | 1.012B |
| March 31, 2024 | 982.27M |
| December 31, 2023 | 1.094B |
| September 30, 2023 | 932.53M |
| June 30, 2023 | 946.10M |
| March 31, 2023 | 927.00M |
| December 31, 2022 | 1.007B |
| September 30, 2022 | 827.68M |
| June 30, 2022 | 872.58M |
| March 31, 2022 | 892.55M |
| December 31, 2021 | 1.012B |
| September 30, 2021 | 891.20M |
| June 30, 2021 | 889.08M |
| March 31, 2021 | 914.20M |
| December 31, 2020 | 914.44M |
| September 30, 2020 | 877.95M |
| June 30, 2020 | 856.40M |
| Date | Value |
|---|---|
| March 31, 2020 | 829.17M |
| December 31, 2019 | 825.45M |
| September 30, 2019 | 741.03M |
| June 30, 2019 | 778.76M |
| March 31, 2019 | 780.46M |
| December 31, 2018 | 745.26M |
| September 30, 2018 | 757.12M |
| June 30, 2018 | 774.90M |
| March 31, 2018 | 812.09M |
| December 31, 2017 | 799.63M |
| September 30, 2017 | 714.88M |
| June 30, 2017 | 703.20M |
| March 31, 2017 | 693.68M |
| December 31, 2016 | 680.75M |
| September 30, 2016 | 682.92M |
| June 30, 2016 | 672.41M |
| March 31, 2016 | 676.51M |
| December 31, 2015 | 618.94M |
| September 30, 2015 | 600.61M |
| June 30, 2015 | 583.84M |
| March 31, 2015 | 514.81M |
| December 31, 2014 | 555.60M |
| September 30, 2014 | 570.88M |
| June 30, 2014 | 609.34M |
| March 31, 2014 | 617.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novo Nordisk A/S | 91.00B |
| H. Lundbeck A/S | 8.061B |
| AstraZeneca PLC | 114.02B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 425.67M |
| Shareholders Equity (Quarterly) | 1.062B |
| Debt to Equity Ratio | 0.0608 |
| Current Ratio | 3.457 |
| Net Debt Paydown Yield | 0.11% |